PPARδ agonist is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Last reviewed on 2025-12-01. Where a claim depends on a specific study, the study is described rather than over-claimed.
Clinical development stopped after rodent studies showed tumors at multiple sites. Whether those findings predict human cancer risk remains an open question, but they led sponsors to discontinue programs. Human safety data are limited to small, short-term studies that were not designed to assess cancer risk. Reported effects in those studies included changes in blood lipids, but the evidence is insufficient for medical use. Long-term consequences of nonmedical use are not well characterized. Questions about dose, duration, and individual susceptibility remain unresolved.
Cardarine is a common name for GW501516, an investigational compound developed in the 1990s for metabolic conditions. It acts as an agonist at peroxisome proliferator-activated receptor delta, a nuclear receptor involved in lipid and energy metabolism. The compound is frequently mislabeled as a selective androgen receptor modulator, or SARM, but its molecular target is different. GW501516 reached early clinical testing before development was discontinued. It has no approved therapeutic use in any country. The name cardarine is not a formal international nonproprietary name.
Regulatory treatment varies, but cardarine is not approved as a medicine. Sports authorities list GW501516 as a prohibited substance, and it is banned at all times under the World Anti-Doping Agency code. Many countries restrict sales for human consumption, while online vendors market it as a research chemical. Such products may lack purity data, and their actual contents can differ from the label. Purchasing or possessing cardarine may carry legal consequences depending on jurisdiction. The compound is not a dietary supplement ingredient in regulated markets.
Anti-doping laboratories identify GW501516 and its metabolites using liquid chromatography-tandem mass spectrometry. Urine is the usual matrix, and detection can occur after the parent compound has cleared from blood. The exact detection window depends on dose, formulation, individual metabolism, and assay sensitivity. Because the compound is prohibited at all times, athletes are subject to testing in and out of competition. Analytical methods continue to improve as new metabolites and designer analogs are characterized.
GW501516 acts as a ligand for PPAR delta, a nuclear receptor that regulates transcription of genes involved in fatty acid oxidation and energy use. Activation of this receptor in skeletal muscle shifts metabolism toward fat burning in animal models. The compound does not burn fat directly; it changes gene expression over hours to days. Researchers study it to understand metabolic flexibility and exercise adaptation. Effects observed in rodents are not automatically expected in humans.
| Property | Value | Notes |
|---|---|---|
| Common synonyms | GW501516; GW-1516; endurobol | GW501516 is the research code |
| Drug class | PPARδ agonist | Not a selective androgen receptor modulator |
| Molecular formula | C21H18F3NO3S2 | Established chemical formula |
| Molar mass | 453.5 g/mol | Calculated from the formula |
| Regulatory status | Prohibited in sport; not approved as medicine | Status varies by country |
The compound is typically described as a laboratory compound rather than a therapeutic product. Published reports have explored its role in lipid disorders, insulin sensitivity, and exercise metabolism, yet no major drug regulator has approved it for medical use. Commercial samples sold under the cardarine name may vary in purity and identity. Analytical confirmation is therefore necessary when the material is discussed in scientific or regulatory contexts. Its classification as a prohibited substance in sport further shapes how it is studied and reported.
Cardarine is a common name for GW501516, a synthetic compound studied for its effects on lipid and glucose metabolism. It functions as an agonist at peroxisome proliferator-activated receptor delta, or PPARδ, a nuclear receptor that influences gene expression. The molecule is not a steroid, nor is it a selective androgen receptor modulator. It is also known in research and sports literature as GW-501516 and endurobol. Early laboratory work examined its metabolic activity in cell cultures and animal models.
Activation of PPARδ changes transcription of genes involved in fatty acid transport, mitochondrial function, and skeletal muscle fuel preference. In rodent studies, pharmacological PPARδ activation was associated with increased endurance and altered body composition. These findings generated interest in performance enhancement, but species differences and study designs limit direct extrapolation to humans. Small human trials were conducted in the 2000s and later discontinued. The extent to which cardarine produces similar metabolic or performance effects in people remains an open question.
Safety discussions about cardarine frequently cite rodent carcinogenicity findings reported in the 2000s. In those studies, treated animals developed tumors at multiple sites, leading sponsors to discontinue clinical development. The relevance of these findings to humans has not been resolved, but they are a major reason the compound is not approved. Current literature emphasizes uncertainty about long-term effects and the risks of unregulated use. Regulators and health agencies have not established a safe human exposure level.
Cardarine is a synthetic compound also known as GW501516, GW-501516, and sometimes endurobol. It was developed as a selective agonist of peroxisome proliferator-activated receptor delta, a nuclear receptor involved in fatty acid oxidation and energy metabolism. The compound was studied in preclinical models for metabolic and cardiovascular conditions, but it did not become a marketed human medicine. In regulatory and anti-doping contexts, it is treated as a prohibited substance rather than a licensed medicine.
The pharmacological interest in cardarine centers on PPARδ activation and its downstream effects on lipid handling and mitochondrial function. In animal studies, PPARδ agonists have been associated with changes in exercise endurance and fatty acid utilization, though results vary by model and protocol. Human data remain sparse, and the absence of large controlled trials limits conclusions about efficacy. Researchers often describe the compound as a tool for probing PPARδ biology rather than a proven therapeutic agent.
==== Hermaphroditism ==== Some teleost species are hermaphroditic, which can come in two forms: simultaneous and sequential. In the former, both spermatozoa and eggs are present in the gonads. Simultaneous hermaphroditism typically occurs in species that live in the ocean depths, where potential mates are sparsely dispersed. Self-fertilisation is rare and has only been recorded in two species, Kryptolebias marmoratus and Kryptolebias hermaphroditus. With sequential hermaphroditism, individuals may function as one sex early in their adult life and switch later in life. Species with this condition include parrotfish, wrasses, sea basses, flatheads, sea breams and lightfishes. Protandry is when an individual starts out male and becomes female while the reverse condition is known as protogyny, the latter being more common. Changing sex can occur in various contexts. In the bluestreak cleaner wrasse, where males have harems of up to ten females, if the male is removed the largest and most dominant female develops male-like behaviour and eventually testes. If she is removed, the next ranking female takes her place. In the species Anthias squamipinnis, where individuals gather into large groups and females greatly outnumber males, if a certain number of males are removed from a group, the same number of females change sex and replace them. In clownfish, individuals live in groups and only the two largest in a group breed: the largest female and the largest male. If the female dies, the male switches sexes and the next largest male takes his place.
On June 3, 1942, which was during World War II, in what were the only two invasions of the United States during the war, small parts of the Aleutian islands were occupied by Japanese forces, when Attu and Kiska were invaded possibly to divert American forces away from the main Japanese attack at Midway Atoll. The U.S. Navy, having broken the Japanese naval codes, proceeded as if this was just a diversion, and it did not expend large amounts of effort in defending the islands. More than 90 Americans were taken to Japan as prisoners of war. The United States moved most of the remaining civilian population (over 800) of the Aleutians and Pribilovians to camps in the Alaska Panhandle. In May 1943, American forces invaded Japanese-held Attu and defeated the Japanese. In August 1943, American and Canadian troops launched an invasion of Kiska, in which 34,426 men composed of both Americans and Canadian participated; however, Japanese forces had already evacuated the island, ending the campaign in the islands. The invasion was an embarrassment for the Allied forces as the entire Japanese force of 5,183 men had left the island on July 28 without the Americans noticing; however, the Americans suffered significant casualties during their "invasion"—313 men died as a result of accidents, with many dying due to accidental fire. President Roosevelt visited Adak in 1944, meeting with commanders and eating with soldiers of the garrison. This was his first and only trip to the Aleutian Islands and Alaska as a whole.
=== Co-evolution of lens and cornea through gene sharing === Based on the similarities between lens and cornea, such as abundant water-soluble enzymes, and being derived from ectoderm, the lens and cornea are thought to be co-evolved as a "refraction unit." Gene sharing would maximize light transmission and refraction to the retina by this refraction unit. Studies have shown that many water-soluble enzymes/proteins expressed by cornea are identical to taxon-specific lens crystallins, such as ALDH1A1/ η-crystallin, α-enolase/τ-crystallin, and lactic dehydrogenase/ -crystallin. Also, the anuran corneal epithelium, which can transdifferentiate to regenerate the lens, abundantly expresses ubiquitous lens crystallins, α, β and γ, in addition to the taxon-specific crystallin α-enolase/τ-crystallin. Overall, the similarity in expression of these proteins in the cornea and lens, both in abundance and taxon-specificity, supports the idea of co-evolution of lens and cornea through gene sharing.
dipolar bond Also coordinate covalent bond, coordinate bond, dative bond, and semipolar bond. A type of covalent bond formed by the coordination of two or more electrically neutral moieties, the combination of which results in a charge-separated molecule or coordination complex, in which two electrons deriving from the same atom are shared between the donor atom and an acceptor atom, creating an internal two-center molecular dipole moment.
{\displaystyle {\begin{aligned}K_{M}\ &{\stackrel {\mathrm {def} }{=}}\ {\frac {k_{2}+k_{-1}}{k_{1}}}\approx K_{D}\\V_{\max }\ &{\stackrel {\mathrm {def} }{=}}\ k_{cat}{\ce {[E]}}_{tot}\end{aligned}}}
Sources: en.wikipedia.org
On February 10, 2025, the AIDS Vaccine Advocacy Coalition and the Journalism Development Network filed suit in the U.S. District Court for the District of Columbia, seeking a preliminary injunction that would prevent the enforcement of Executive Order 14169, along with an order reinstating foreign assistance funding. On February 13, 2025, U.S. district court Judge Amir Ali granted a temporary restraining order (TRO) and told the government to pay $2 billion in funds that were owed to aid agencies. The government did not comply, leading the plaintiffs to return to court to seek enforcement, and Judge Ali gave the government until February 26 to comply. The Trump administration appealed that ruling to the U.S. Court of Appeals for the District of Columbia, also requesting a stay pending appeal; the stay was rejected. The administration then appealed to the U.S. Supreme Court, asking the court to vacate the TRO and grant the stay while the appeal proceeded in the appeals court. On March 5, 2025, the United States Supreme Court ruled 5-4 that the federal government must pay for projects already completed. Voting in the majority were the 3 Democratic appointees, Chief Justice Roberts, and Justice Barrett; voting in the minority were the other 4 Republican appointees. However, Federal Judge Ali was ordered to proceed with "due regard for the feasibility of any compliance timelines." On March 6, Judge Ali ruled that at least some payments for completed work must be made by March 10.
== Indications and Usage == In 1997, the United States Food and Drug Administration approved difloxacin hydrochloride tablets for use in canines. Unlike other fluoroquinolones difloxacin has not been approved by the FDA for use in cats. It is also contraindicated for use in food animals. The recommended dosing is 5–10 mg/kg once daily. This is based on the linear pharmacokinetics exhibited by difloxacin over the 5–60 mg/kg range. So the maximum dose is well within the established safety range, but drug accumulation in tissues prompts a recommendation that the medication should not be used for periods longer than thirty days. If there is no noticeable improvement after five days, then the condition should be reevaluated and all therapy options reconsidered. Difloxacin is indicated for infections caused by susceptible microorganisms in the conditions listed below.
Terrebonne (French pronunciation: [tɛʁbɔn]) is a federal electoral district in the Canadian province of Quebec. It was represented in the House of Commons of Canada from 1867 to 1997, when it was dissolved in an electoral redistribution. It was reconstituted as an electoral district beginning with the 2015 election.
==== Off-label use ==== Doxycycline is used off-label in the treatment of transthyretin amyloidosis (ATTR). In combination with tauroursodeoxycholic acid, doxycycline has been shown to disrupt transthyretin (TTR) fibrils in existing amyloid deposits of ATTR patients, and is being investigated as a potential treatment option for this condition.
In this way protein dynamics can induce a conformational change in the structure of the protein via long-range allostery with other hydrophobic and hydrophilic residues in the protein. One such example of the regulatory role that phosphorylation plays is the p53 tumor suppressor protein. The p53 protein is heavily regulated and contains more than 18 different phosphorylation sites. Activation of p53 can lead to cell cycle arrest, which can be reversed under some circumstances, or apoptotic cell death. This activity occurs only in situations wherein the cell is damaged or physiology is disturbed in normal healthy individuals. Upon the deactivating signal, the protein becomes dephosphorylated again and stops working. This is the mechanism in many forms of signal transduction, for example the way in which incoming light is processed in the light-sensitive cells of the retina. Regulatory roles of phosphorylation include:
Sources: en.wikipedia.org
No. Cardarine is GW501516, a PPARδ agonist, while SARMs act on androgen receptors. The two classes are often grouped in informal discussions despite different mechanisms.
No. It has no approved medical indication in any country. Regulatory agencies have not cleared it for treatment or prevention of any condition.
Early clinical work stopped after rodent carcinogenicity findings. Those animal results raised concerns about long-term human risk, although direct human evidence is lacking. The human relevance of the tumors remains an open scientific question.
It binds to and activates PPAR delta, a nuclear receptor that controls expression of genes related to fatty acid oxidation. This mechanism can alter energy metabolism in animal models. It is not a direct stimulant or fat-burning enzyme.